<i>Caenorhabditis elegans</i> Models to Investigate the Mechanisms Underlying Tau Toxicity in Tauopathies

The understanding of the genetic, biochemical, and structural determinants underlying tau aggregation is pivotal in the elucidation of the pathogenic process driving tauopathies and the design of effective therapies. Relevant information on the molecular basis of human neurodegeneration in vivo can...

Full description

Bibliographic Details
Main Authors: Carmina Natale, Maria Monica Barzago, Luisa Diomede
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Brain Sciences
Subjects:
tau
Online Access:https://www.mdpi.com/2076-3425/10/11/838
id doaj-b44ae9444aaa4acdb346b0be76fd263b
record_format Article
spelling doaj-b44ae9444aaa4acdb346b0be76fd263b2020-11-25T04:00:16ZengMDPI AGBrain Sciences2076-34252020-11-011083883810.3390/brainsci10110838<i>Caenorhabditis elegans</i> Models to Investigate the Mechanisms Underlying Tau Toxicity in TauopathiesCarmina Natale0Maria Monica Barzago1Luisa Diomede2Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, ItalyDepartment of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, ItalyDepartment of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, ItalyThe understanding of the genetic, biochemical, and structural determinants underlying tau aggregation is pivotal in the elucidation of the pathogenic process driving tauopathies and the design of effective therapies. Relevant information on the molecular basis of human neurodegeneration in vivo can be obtained using the nematode <i>Caenorhabditis elegans</i> (<i>C. elegans</i>). To this end, two main approaches can be applied: the overexpression of genes/proteins leading to neuronal dysfunction and death, and studies in which proteins prone to misfolding are exogenously administered to induce a neurotoxic phenotype. Thanks to the easy generation of transgenic strains expressing human disease genes, <i>C. elegans</i> allows the identification of genes and/or proteins specifically associated with pathology and the specific disruptions of cellular processes involved in disease. Several transgenic strains expressing human wild-type or mutated tau have been developed and offer significant information concerning whether transgene expression regulates protein production and aggregation in soluble or insoluble form, onset of the disease, and the degenerative process. <i>C. elegans</i> is able to specifically react to the toxic assemblies of tau, thus developing a neurodegenerative phenotype that, even when exogenously administered, opens up the use of this assay to investigate in vivo the relationship between the tau sequence, its folding, and its proteotoxicity. These approaches can be employed to screen drugs and small molecules that can interact with the biogenesis and dynamics of formation of tau aggregates and to analyze their interactions with other cellular proteins.https://www.mdpi.com/2076-3425/10/11/838<i>Caenorhabditis elegans</i>tautauopathyfrontotemporal dementiamicrotubule-associated protein tauproteotoxicity
collection DOAJ
language English
format Article
sources DOAJ
author Carmina Natale
Maria Monica Barzago
Luisa Diomede
spellingShingle Carmina Natale
Maria Monica Barzago
Luisa Diomede
<i>Caenorhabditis elegans</i> Models to Investigate the Mechanisms Underlying Tau Toxicity in Tauopathies
Brain Sciences
<i>Caenorhabditis elegans</i>
tau
tauopathy
frontotemporal dementia
microtubule-associated protein tau
proteotoxicity
author_facet Carmina Natale
Maria Monica Barzago
Luisa Diomede
author_sort Carmina Natale
title <i>Caenorhabditis elegans</i> Models to Investigate the Mechanisms Underlying Tau Toxicity in Tauopathies
title_short <i>Caenorhabditis elegans</i> Models to Investigate the Mechanisms Underlying Tau Toxicity in Tauopathies
title_full <i>Caenorhabditis elegans</i> Models to Investigate the Mechanisms Underlying Tau Toxicity in Tauopathies
title_fullStr <i>Caenorhabditis elegans</i> Models to Investigate the Mechanisms Underlying Tau Toxicity in Tauopathies
title_full_unstemmed <i>Caenorhabditis elegans</i> Models to Investigate the Mechanisms Underlying Tau Toxicity in Tauopathies
title_sort <i>caenorhabditis elegans</i> models to investigate the mechanisms underlying tau toxicity in tauopathies
publisher MDPI AG
series Brain Sciences
issn 2076-3425
publishDate 2020-11-01
description The understanding of the genetic, biochemical, and structural determinants underlying tau aggregation is pivotal in the elucidation of the pathogenic process driving tauopathies and the design of effective therapies. Relevant information on the molecular basis of human neurodegeneration in vivo can be obtained using the nematode <i>Caenorhabditis elegans</i> (<i>C. elegans</i>). To this end, two main approaches can be applied: the overexpression of genes/proteins leading to neuronal dysfunction and death, and studies in which proteins prone to misfolding are exogenously administered to induce a neurotoxic phenotype. Thanks to the easy generation of transgenic strains expressing human disease genes, <i>C. elegans</i> allows the identification of genes and/or proteins specifically associated with pathology and the specific disruptions of cellular processes involved in disease. Several transgenic strains expressing human wild-type or mutated tau have been developed and offer significant information concerning whether transgene expression regulates protein production and aggregation in soluble or insoluble form, onset of the disease, and the degenerative process. <i>C. elegans</i> is able to specifically react to the toxic assemblies of tau, thus developing a neurodegenerative phenotype that, even when exogenously administered, opens up the use of this assay to investigate in vivo the relationship between the tau sequence, its folding, and its proteotoxicity. These approaches can be employed to screen drugs and small molecules that can interact with the biogenesis and dynamics of formation of tau aggregates and to analyze their interactions with other cellular proteins.
topic <i>Caenorhabditis elegans</i>
tau
tauopathy
frontotemporal dementia
microtubule-associated protein tau
proteotoxicity
url https://www.mdpi.com/2076-3425/10/11/838
work_keys_str_mv AT carminanatale icaenorhabditiselegansimodelstoinvestigatethemechanismsunderlyingtautoxicityintauopathies
AT mariamonicabarzago icaenorhabditiselegansimodelstoinvestigatethemechanismsunderlyingtautoxicityintauopathies
AT luisadiomede icaenorhabditiselegansimodelstoinvestigatethemechanismsunderlyingtautoxicityintauopathies
_version_ 1724451535171092480